Teva’s Nuvigil Label-Expansion Effort Shows No Signs Of Fatigue Even After Bipolar Depression Failure

Attempts to expand armodafinil labeling have also included unsuccessful efforts in schizophrenia and jet lag, but Teva has more indications it would like to try with the wakefulness aid.